Photodynamic Therapy Mediated by Topical Application of 5- ALA for the Treatment of Actinic Keratoses

Withdrawn before enrolling · Not applicable

Conditions studied: Actinic Keratosis

In brief

The purpose of this study is to compare the treatment of skin growths called actinic keratoses (AK) with 5-ALA PDT, an FDA-approved treatment, versus treatment with other conventionally used FDA-approved agents such as cryotherapy, Imiquimod, or 5-fluorouracil (5-FU).

Key facts

Study ID

NCT00814528

Run by

University of Chicago

People needed

0

Starts

2007-11-01

Expected to finish

2009-09-01

Last updated by the study team

2018-09-10

Who can join

Age: 18 and older, up to 95. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-95 years old
• Diagnosied with actinic keratoses.

You may not qualify if…

• Patients who have had Isotretinoin therapy less that 1 year prior to screening.
• Patients who have an adverse reaction to light exposure (for example photo- exacerbated seizures).
• History of porphyria

Where it is running

• The University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.